Pathstone Holdings’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$536K Sell
20,816
-566
-3% -$13.1K ﹤0.01% 1835
2026
Q1
$440K Buy
21,382
+747
+4% +$16.8K ﹤0.01% 1801
2025
Q4
$489K Buy
+20,635
New +$502K ﹤0.01% 1755

Other funds holding PRVA

Pathstone Holdings's PRVA Position: Q2 2026 in Review

Pathstone Holdings reduced its Privia Health (PRVA) stake by 2.6% in Q2 2026, selling an estimated $13.1K and leaving 20,816 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

Pathstone Holdings first reported a position in PRVA in Q4 2025 and has held it in 3 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Pathstone Holdings held 20,816 shares of Privia Health worth $536K as of Q2 2026.
  • Pathstone Holdings sold 566 Privia Health shares in Q2 2026, an estimated $13.1K.
  • Privia Health made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1835 holding.
  • Pathstone Holdings first reported a position in Privia Health in Q4 2025 and has held it in 3 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.